How should CAR-T therapy be priced?
As with all things, we should be concerned with value, not price. Novartis’ pricing scheme easily passes the value test. There is no objective value that can be put on saving a life, of course. But we can still make estimates. Britain’s National Institute on Cost Effectiveness (NICE) evaluates treatments with respect to their value. Read More …